Skip to main content
Premium Trial:

Request an Annual Quote

PathoGenetix Raises $10M in Series C Round

NEW YORK (GenomeWeb News) – PathoGenetix today announced it has secured $10 million in Series C financing to further commercialization efforts for its Genome Sequence Scanning technology.

Participants in the round included existing investors Ascension Health Ventures, Excel Venture Management, and HealthCare Ventures. The funding, PathoGenetix said, will be directed at further development of its first commercial system using the GSS technology, called the Resolution Microbial Genotyping System.

The platform includes the instrument, bioinformatics software and database, as well as pathogen-specific assays. Woburn, Mass.-based PathoGenetix said that it anticipates launching the Resolution System in 2014 for food safety testing applications and foodborne illness outbreak investigations.

GSS is culture independent and fully automated from sample preparation to final report, resulting in a reduction in time, complexity, skill, and cost required for its use, compared to other molecular and next-generation sequencing-based approaches, PathoGenetix said. Additionally, GSS provides strain-type information that is comparable to pulsed field gel electrophoresis, the current standard for pathogen typing in foodborne outbreak investigation and response, it added.

Today's deal follows agreements PathoGenetix announced with the US Food and Drug Administration in April, and the US Department of Agriculture's Agricultural Research Service in September. The same month, it forged a deal with Applied Maths focused on rapid pathogen strain typing. The company today said that it is currently conducting customer evaluations with "leading food safety testing labs."

In 2011 PathoGenetix raised $11.5 million in a Series B round. Earlier this month, the company said in a regulatory document that it raised $3.6 million toward a targeted $9.1 million round. That raise was part of the $10M Series C found, a company spokesman said.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.